최소 단어 이상 선택하여야 합니다.
최대 10 단어까지만 선택 가능합니다.
다음과 같은 기능을 한번의 로그인으로 사용 할 수 있습니다.
NTIS 바로가기대한한방내과학회지 = The journal of internal Korean medicine, v.41 no.3, 2020년, pp.424 - 433
강보형 (가천대학교 한의과대학 한방내과교실) , 최유경 (가천대학교 한의과대학 한방내과교실) , 전찬용 (가천대학교 한의과대학 한방내과교실) , 양승보 (가천대학교 한의과대학 한방내과교실)
Qingfei Paidu decoction is recommended for treatment and prevention of COVID-19. It is a prescription that combines Mahaenggamseok-tang, Oryeong-san, Soshiho-tang, Saganmahwang-tang, and Kwakhyangjeonggi-san. According to several clinical reviews, symptoms of COVID-19 were improved, laboratory test ...
* AI 자동 식별 결과로 적합하지 않은 문장이 있을 수 있으니, 이용에 유의하시기 바랍니다.
핵심어 | 질문 | 논문에서 추출한 답변 |
---|---|---|
Corona Virus Dieaese-19(이하 COVID-19)는 무엇인가? | Corona Virus Dieaese-19(이하 COVID-19)는 2019 년 신종 코로나바이러스에 의해 일어난 폐렴으로, 중국 우한에서 처음 발생한 이후 전 세계로 확산 되어 공중위생 사건을 일으킴과 동시에 수많은 사 상자가 발생하고 있다. 하지만 아직까지 효과적인 표적 약물이나 백신이 확인되지 않아 Lopinavir, Ritonavir 등의 항바이러스제나 interferon, steroid 등의 약물이나 수액보충, 해열제 등을 이용한 보존적 치료를 시도하고 있는 상황이다1 | |
COVID 19의 치료에 활용해 볼 수 있을 것으로 사료되는 이유는 무엇인가? | 청폐배독탕은 현재까지 보고된 임상 증례 결과 COVID-19의 증상인 발열, 기침 등의 폐렴 증상이 개선되었고, 실험실 혈액 검사 지표인 림프구 백분율, AST, ALT, D-dimer 등이 정상으로 돌아왔으며, 폐 CT 영상 판독 결과 높은 회복율을 보인 바 있다. 또한 구성 약재의 항바이러스, 항염증 및 면역 조절 효과가 보고되었으며, 심각한 부작용 사례는 아직까지 보고되지 않았다. 따라서 효과적인 표적 약물이 개발되지 않은 현재 시점에서 COVID 19의 치료에 활용해 볼 수 있을 것으로 사료된다. | |
청폐배독탕의 임상 증례 결과 입증된 효능은 무엇인가? | 청폐배독탕은 현재까지 보고된 임상 증례 결과 COVID-19의 증상인 발열, 기침 등의 폐렴 증상이 개선되었고, 실험실 혈액 검사 지표인 림프구 백분율, AST, ALT, D-dimer 등이 정상으로 돌아왔으며, 폐 CT 영상 판독 결과 높은 회복율을 보인 바 있다. 또한 구성 약재의 항바이러스, 항염증 및 면역 조절 효과가 보고되었으며, 심각한 부작용 사례는 아직까지 보고되지 않았다. |
장인수, 양승보, 백유상, 정창현, 장우창, 권승원, 등. 코로나바이러스감염증-19 한의진료 권고안. 2nd edition. 서울: 사단법인대한한의사협회; 2020, p. 1-52.
Lau JT, Leung P, Wong E, Fong C, Cheng K, Zhang S, et al. The use of an herbal formula by hospital care workers during the severe acute respiratory syndrome epidemic in Hong Kong to prevent severe acute respiratory syndrome transmission, relieve influenza-related symptoms, and improve quality of life: a prospective cohort study. Journal of Alternative & Complementary Medicine 2005;11(1):49-55.
Yang ZF, Leung ELH, Liu L, Jiang ZH, Zhong N. Developing influenza treatments using traditional Chinese medicine. Science 2015;347(6219):S35-S7.
Jiang L, Deng L, Wu T. Chinese medicinal herbs for influenza. Cochrane Database of Systematic Reviews 2013;(3):CD004559.
Jiang YJ, Lian YJ, Li J, Liu HX. Study on Pneumonia Prescription of Traditional Chinese Medicine to Prevent Novel Coronavirus Infection in Different Regions Based on Data Mining. World Chinese Medicine 2020;15(3):325-31.
Wang X, Liu Z. Prevention and treatment of viral respiratory infections by traditional Chinese herbs. Chinese medical journal 2014;127(7):1344-50.
Shen AM, Zhang W, Wu Z, Wang WL, Hua JJ. TCM Theory analysis of Qing-Fei-Pai-Du-Tang in treating COVID-19. Liaoning Journal of Traditional Chinese Medicine 2020;(3):106-8.
?子 小. COVID-19 感染症に?する漢方治療の考え方. 日本の感染?? 2020;3:1-5.
Yang Y, Islam MS, Wang J, Li Y, Chen X. Traditional Chinese medicine in the treatment of patients infected with 2019-new coronavirus (SARS-CoV-2): a review and perspective. International journal of biological sciences 2020;16(10):1708-17.
이범준, 정희재, 최준용, 김관일. 코로나바이러스감염증-19 한의지료 지침. 2.1 edition. 서울: 전국한의과대학폐계내과협의회; 2020, p. 1-13.
고흥, 손성세, 송미덕, 윤성중, 윤종현, 이범준, 등. 코로나바이러스감염증-19 한의전화진료 가이드. 1st edition. 서울: 사단법인대한한의사협회; 2020, p. 1-45.
薛伯?, 姚魁武, 薛燕星. "?肺排毒?" 快速有效治?新型冠?病毒肺炎的中?理?分析. 中??志 2020;61(6):461-2.
Wang RQ, Yang SJ, Xie CG, Shen QL, Li MQ, Lei X, et al. Clinical Observation of Qingfeipaidu Decoction in the Treatment of COVID-19. Pharmacology and Clinics of Chinese Materia Medica 2020;36(1):13-8.
路志正 路. "?肺排毒?" 彰?中??抗疫?效?自信. 中??志 2020;10:833-4.
Wu H, Wang JQ, Yang YW, Li TY, Cao YJ, Qu YX, et al. Preliminary exploration of the mechanism of Qingfei Paidu decoction against novel coronavirus pneumonia based on network pharmacology and molecular docking technology. Acta Pharmaceutica Sinica 2020;55(3):374-83.
Zhao J, Tian SS, Yang J, Liu JF, Zhang WD. Investigating mechanism of Qing-Fei-Pai-Du-Tang for treatment of COVID-19 by network pharmacology. Chin Trad Herbal Drugs 2020;51(4):829-35.
진조조. 중의치법과 방제. 서울: 정담; 2009, p. 306, 527, 300, 1170.
Zhang HL, Huang ZG, Jiang X, Qiu Y, Huang TM, Lin ZQ, et al. Study on the Mechanism of Maxing Shigan Decoction in the Treatment of the Severe Novel Coronavirus Pneumonia Based on Network Pharmacology. Journal of Chinese Medicinal Materials 2000;(03):1-8.
Hsieh CF, Lo CW, Liu CH, Lin S, Yen HR, Lin TY, et al. Mechanism by which ma-xing-shi-gan-tang inhibits the entry of influenza virus. Journal of ethnopharmacology 2012;143(1):57-67.
Zhong Y, Zhou J, Liang N, Liu B, Lu R, He Y, et al. Effect of Maxing Shigan Tang on H1N1 influenza A virus-associated acute lung injury in mice. Intervirology 2016;59(5-6):267-74.
Kao ST, Yeh TJ, Hsieh CC, Shiau HB, Yeh FT, Lin JG. The effects of Ma-Xing-Gan-Shi-Tang on respiratory resistance and airway leukocyte infiltration in asthmatic guinea pigs. Immunopharmacology and immunotoxicology 2001;23(3):445-58.
吉益東洞. 약징. 서울: 청홍; 2010, p. 95-100, 61-4.
한방약리학교재편찬위원회. 한방약리학. 서울: 신일북스; 2015, p. 119-30, 321-8.
한의과대학방제학교실. 방제학. 서울: 영림사; 2009, p. 504-5.
Matsukawa T, Miyamoto T. Angiotensin II-stimulated secretion of arginine vasopressin is inhibited by atrial natriuretic peptide in humans. American Journal of Physiology-Regulatory, Integrative and Comparative Physiology 2011;300(3):R624-R9.
Boldt J, Suttner S. Physiology and pathophysiology of the natriuretic peptide system. Yearbook of Intensive Care and Emergency Medicine. Berlin, Heidelberg: Springer; 2006, p. 101-9.
Task Force for Clinical Practice Guidelines (CPG-TF) Committee for EBM. Clinical Practice Guidelines Containing kampo Products in Japan(KCPG) Appendix 2018. The Japan Society for Oriental Medicine (JSOM). 2019, p. 1-8.
中?中西??合?志. 新型冠?病毒肺炎??方案(?行第五版 修正版). 中?中西??合?志 2020;40(2):136-8.
Furukawa M, Sakashita H, Kamide M, Umeda R. Inhibitory effects of kampo medicine on Epstein-Barr virus antigen induction by tumor promoter. Auris Nasus Larynx 1990;17(1):49-54.
Yamashiki M, Nishimura A, Huang XX, Nobori T, Sakaguchi S, Suzuki H. Effects of the Japanese herbal medicine "Sho-saiko-to"(TJ-9) on interleukin-12 production in patients with HCV-positive liver cirrhosis. Clinical and Developmental Immunology 1999;7(1):17-22.
Yamashiki M, Nishimura A, Suzuki H, Sakaguchi S, Kosaka Y. Effects of the Japanese herbal medicine "Sho-Saiko-To"(TJ-9) on in vitro interleukin-10 production by peripheral blood mononuclear cells of patients with chronic hepatitis C. Hepatology 1997;25(6):1390-7.
Yamashiki M, Nishimura A, Nobori T, Nakabayashi S, Takagi T, Inoue K, et al. In vitro effects of Sho-saiko-to on production of granulocyte colony-stimulating factor by mononuclear cells from patients with chronic hepatitis C. International journal of immunopharmacology 1997;19(7):381-5.
Kubo T, Nishimura H. Antipyretic effect of Mao-to, a Japanese herbal medicine, for treatment of type A influenza infection in children. Phytomedicine 2007;14(2-3):96-101.
川村?一. インフルエンザ患者に?する麻?湯の有?性の?討. 日本臨床?科???誌 2007;22(4):435-8.
芦原貴司. ザナミビルに麻?湯を?用し緩徐な解熱が得られた小?インフルエンザの 1 症例. 漢方?? 2010;34(2):201-3.
?豪, ???, 沈旭波, ?可君. 射干麻???哮喘性肺炎大鼠肺部炎症反?及免疫反?的影?. ?州中??大??? 2020;37(2):317-23.
Shijie Z, Moriya J, Yamakawa Ji, Chen R, Takahashi T, Sumino H, et al. Mao-to prolongs the survival of and reduces $TNF-{\alpha}$ expression in mice with viral myocarditis. Evidence-Based Complementary and Alternative Medicine 2010;7(3):341-9.
Orihara Y, Hamamoto H, Kasuga H, Shimada T, Kawaguchi Y, Sekimizu K. A silkworm-baculovirus model for assessing the therapeutic effects of antiviral compounds: characterization and application to the isolation of antivirals from traditional medicines. Journal of general virology 2008;89(1):188-94.
Murakami T, Harada H, Suico MA, Shuto T, Suzu S, Kai H, et al. Ephedrae herba, a component of Japanese herbal medicine Mao-to, efficiently activates the replication of latent human immunodeficiency virus type 1 (HIV-1) in a monocytic cell line. Biological and Pharmaceutical Bulletin 2008;31(12):2334-7.
Park JS, Woo MS, Kim DH, Hyun JW, Kim WK, Lee JC, et al. Anti-inflammatory mechanisms of isoflavone metabolites in lipopolysaccharide-stimulated microglial cells. Journal of Pharmacology and Experimental Therapeutics 2007;320(3):1237-45.
Kang KA, Zhang R, Piao MJ, Ko DO, Wang ZH, Kim BJ, et al. Protective effect of irisolidone, a metabolite of kakkalide, against hydrogen peroxide induced cell damage via antioxidant effect. Bioorganic & medicinal chemistry 2008;16(3):1133-41.
Zhao M, Chen Y, Wang C, Xiao W, Chen S, Zhang S, et al. Systems pharmacology dissection of multi-scale mechanisms of action of Huo-Xiang-Zheng-Qi formula for the treatment of gastrointestinal diseases. Frontiers in Pharmacology 2019;9:1448.
Li X, Xie P, Hou Y, Chen S, He P, Xiao Z, et al. Tangeretin inhibits oxidative stress and inflammation via upregulating Nrf-2 signaling pathway in collagen-induced arthritic rats. Pharmacology 2019;104(3-4):187-95.
Zhao S, Liu Z, Wang M, He D, Liu L, Shu Y, et al. Anti-inflammatory effects of Zhishi and Zhiqiao revealed by network pharmacology integrated with molecular mechanism and metabolomics studies. Phytomedicine 2018;50:61-72.
Kim SJ, Park SK. Antioxidative and Anti-inflammatory Effects of Aurantii Fructus Immaturus Pharmacopuncture. Korean Journal of Acupuncture 2010;27(2):13-24.
Choi GY, Kim BW. Experimental Study on the Antioxidant and Antimicrobial Properties of Dioscoreae Rhizoma. The Journal of Korean Oriental Internal Medicine 2010;31(2):290-7.
Kim MJ, Kim HN, Kang KS, Baek NI, Kim DK, Kim YS, et al. Methanol extract of Dioscoreae Rhizoma inhibits pro-inflammatory cytokines and mediators in the synoviocytes of rheumatoid arthritis. International immunopharmacology 2004;4(12):1489-97.
Yang JM, Lee JH, Sung JS, Kim DI. Proteomic Approach to Study the Antioxidant Activities of Dioscoreae Rhizoma on HeLa Cells. The Journal of Oriental Gynecology 2008;21(2):108-24.
Jun YJ, Son MY, Khil MJ, Sung JS, Jeong JC, Kim DI. Cell differentiation and Anti-oxydative effect of Dioscoreae Rhizoma on HeLa Cell. The Journal Of Oriental Gynecology 2007;20(2):139-54.
Shin SW, Lee YS, Park JH, Kwon TK, Suh SI, Kwon YK. Comparison of Immunomodualtory Effects of Water-extracted Ginseng Radix, Pilose Asia-bell, Astragali Radix, Astractylodes Rhizoma alba and Dioscoreae Rhizoma. Korean Journal of Oriental Physiology & Pathology 2004;18(4):1140-6.
Ryu HC, Shin JG. A study on proper dosage of Ma-huang(麻黃). The Journal of Korean Medical Association of Clinical Sanghan-Geumgwe 2013;5(1):101-11.
Kim HS, Lee SI. A Study for Safe Dose and Clinical Use of Glycyrrhizae Radix in Shanghanlun. The Journal of Korean Medical Association of Clinical Sanghan-Geumgwe 2016;8(1):1-23.
Lee I, Park SM, Park SC, Kim DH, Cho MK, Han CW, et al. Overview of the Interaction between Warfarin and Korean Herbal Medicine. The Journal of Korean Oriental Internal Medicine 2012;33(2):160-71.
Ishizaki T, Sasaki F, Ameshima S, Shiozaki K, Takahashi H, Abe Y, et al. Pneumonitis during interferon and/or herbal drug therapy in patients with chronic active hepatitis. European Respiratory Journal 1996;9(12):2691-96.
*원문 PDF 파일 및 링크정보가 존재하지 않을 경우 KISTI DDS 시스템에서 제공하는 원문복사서비스를 사용할 수 있습니다.
오픈액세스 학술지에 출판된 논문
※ AI-Helper는 부적절한 답변을 할 수 있습니다.